Omalizumab for food allergy skin effects
Treatments studied
Part of Immune system & allergy clinical trials.
This trial tests if omalizumab (Xolair) can improve skin reactions in people with food allergies. It may help reduce allergic symptoms triggered by foods like peanut, egg, or milk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 55 years old.
- You have a confirmed food allergy to peanut, egg, tree nut, sesame, milk, wheat, or soy.
- Your IgE level and weight must allow a safe omalizumab dose.
- You must be willing to use birth control if you could become pregnant.
- You cannot have severe asthma or eczema that is not well controlled.
- You must stop certain allergy medicines (like antihistamines) before the food challenge.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if omalizumab (a drug that blocks allergy reactions) can help people with multiple food allergies. You might qualify if you have severe allergies to at least two foods like peanut, tree nuts, egg, or milk.
This study gives a few doses of omalizumab (a medicine that blocks allergic reactions) and then does a food challenge to see if the patient can eat the food safely. It is for people who have already been prescribed this medicine for food allergy.
This trial studies an oral immunotherapy approach, where children take tiny, controlled amounts of certain allergy-causing foods to build tolerance. It may help reduce allergic reactions, but only if kids meet safety and monitoring requirements.
This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.
This study tests if omalizumab (Xolair), an injectable medicine that blocks allergy antibodies, can help people with food allergies tolerate small amounts of their trigger foods. It's for people with high total IgE levels who were not eligible for a related study.
This study tests a medication called omalizumab (a common allergy drug) to see if it can help people with severe allergies to plant foods like peach and melon, especially when standard treatments have failed. If you qualify, you may receive the drug and be monitored to see if your food allergies improve.
Hear when a new Food Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.